Therefore, we knocked down or overexpressed BTN3A3 in ovarian cancer cell lines to detect cell proliferation, migration and invasion ability, and used immunoprecipitation combined with mass spectrometry to explore the possible mechanism of BTN3A3 in the progression of ovarian cancer. The gene discussed is BTN3A3; the disease is ovarian carcinoma.